Ionis Pharmaceuticals, Inc.
METHODS AND COMPOSITIONS FOR INHIBITING PMP22 EXPRESSION

Last updated:

Abstract:

The present embodiments provide methods, compounds, and compositions useful for inhibiting PMP22 expression and for treating, preventing, or ameliorating a disease associated with PMP22.

Status:
Application
Type:

Utility

Filling date:

4 Oct 2021

Issue date:

11 Aug 2022